Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

DaVita share price today

DaVita Inc. · DVA · Healthcare · Medical Care Facilities · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

DaVita share price: $192.66 at the close on 4 November 2026, +55.8% in a year.

MixedBusiness trend from the last 12 quarters
$192.66Price +55.8% in a year
14.2×P/E over 4.6 years
$3.6 BRevenue (Jun 2026) +5.2% on a year ago
$343 MProfit (Jun 2026) +24.7% on a year ago
16.1%Operating margin +0.4 points on a year ago
93%ROE FY25
12.2%ROIC against a 5.9% cost of capital: +6.3 points

DaVita Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

The main question: the share price moved +55.8% in a year while yearly earnings per share moved −8.3%. The difference came from the market paying a higher multiple.

The price has been rising for 21 weeks. Over the last four quarters, results have been improving, with profit +24.7% on a year earlier, and 182% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.

What is the DaVita share price today?

DaVita Inc.'s share price was $192.66 at the close on 4 November 2026. It has been rising for 21 weeks. That is 8.1% above its average price over the last 200 trading days. In the last 52 weeks it traded between $105 and $240, and at that close it sat 65% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today DaVita Inc. is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row.

1Y

Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.

  • Price $192.66
  • 50-day avg $182.05
  • 200-day avg $178.24
Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$119.02$130.86$142.65
7 Nov 2025$123.69$129.17$141.48
14 Nov 2025$121.55$127.70$140.19
21 Nov 2025$120.25$125.99$138.71
28 Nov 2025$119.68$125.22$137.65
5 Dec 2025$117.39$123.89$136.65
12 Dec 2025$121.35$122.58$136.02
19 Dec 2025$115.20$121.45$135.40
26 Dec 2025$113.98$120.63$134.76
2 Jan 2026$114.51$119.59$134.12
9 Jan 2026$111.45$117.95$133.19
16 Jan 2026$104.74$116.47$132.04
23 Jan 2026$108.12$115.28$131.16
30 Jan 2026$109.34$113.84$130.06
6 Feb 2026$140.83$115.67$129.97
13 Feb 2026$148.95$118.08$130.07
20 Feb 2026$150.73$120.60$130.22
27 Feb 2026$156.30$123.87$130.43
6 Mar 2026$150.76$127.42$130.65
13 Mar 2026$150.72$131.27$130.95
20 Mar 2026$149.31$134.83$131.28
27 Mar 2026$154.43$139.42$131.70
2 Apr 2026$145.58$143.04$131.96
10 Apr 2026$150.05$147.30$132.27
17 Apr 2026$147.91$150.04$132.42
24 Apr 2026$151.85$150.98$132.64
1 May 2026$151.65$151.27$132.89
8 May 2026$198.65$154.17$133.78
15 May 2026$199.74$158.62$135.10
22 May 2026$198.52$163.13$136.61
29 May 2026$194.36$166.82$137.92
5 Jun 2026$192.16$170.76$139.34
12 Jun 2026$208.66$175.44$140.89
18 Jun 2026$207.91$180.31$142.33
26 Jun 2026$217.04$186.66$144.25
2 Jul 2026$234.91$192.86$146.13
10 Jul 2026$232.80$200.93$148.69
17 Jul 2026$236.97$208.94$151.26
24 Jul 2026$235.44$212.64$153.84
31 Jul 2026$240.09$216.86$156.65
7 Aug 2026$183.77$217.47$158.56
14 Aug 2026$180.06$216.24$159.86
21 Aug 2026$173.82$214.40$161.20
28 Aug 2026$180.68$211.44$162.63
4 Sep 2026$183.99$208.28$164.08
11 Sep 2026$181.55$205.06$165.37
18 Sep 2026$183.86$200.58$167.08
25 Sep 2026$178.47$195.29$168.64
2 Oct 2026$178.69$189.47$170.08
9 Oct 2026$179.25$183.49$171.62
16 Oct 2026$187.31$180.49$173.37
23 Oct 2026$183.64$180.53$175.07
30 Oct 2026$187.50$181.40$177.01
4 Nov 2026$192.66$182.05$178.24
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.

  • Price $192.66
  • 50-day avg $182.05
  • 200-day avg $178.24
Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023$79.45$90.25$91.19
10 Nov 2023$82.99$88.29$91.27
17 Nov 2023$96.16$87.82$91.52
24 Nov 2023$99.26$87.84$91.80
1 Dec 2023$104.31$87.81$92.25
8 Dec 2023$107.58$88.68$92.80
15 Dec 2023$105.69$90.07$93.43
22 Dec 2023$104.33$92.22$94.08
29 Dec 2023$104.76$94.51$94.66
5 Jan 2024$107.24$96.64$95.23
12 Jan 2024$109.10$99.83$96.05
19 Jan 2024$104.76$101.95$96.54
26 Jan 2024$107.17$104.09$97.11
2 Feb 2024$111.21$105.53$97.75
9 Feb 2024$109.86$106.73$98.39
16 Feb 2024$122.22$108.27$99.14
23 Feb 2024$125.26$109.62$99.83
1 Mar 2024$126.92$111.54$100.57
8 Mar 2024$135.17$114.30$101.39
15 Mar 2024$136.65$117.51$102.44
22 Mar 2024$134.11$120.39$103.44
28 Mar 2024$138.05$122.72$104.18
5 Apr 2024$133.61$125.75$105.11
12 Apr 2024$130.42$128.22$105.99
19 Apr 2024$127.82$129.88$106.70
26 Apr 2024$133.51$131.75$107.44
3 May 2024$134.45$133.45$108.30
10 May 2024$137.52$134.53$109.15
17 May 2024$139.82$135.22$110.05
24 May 2024$138.54$135.23$110.76
31 May 2024$147.12$135.91$111.54
7 Jun 2024$143.18$136.78$112.59
14 Jun 2024$141.16$137.35$113.60
21 Jun 2024$141.38$137.98$114.40
28 Jun 2024$138.57$139.18$115.53
5 Jul 2024$136.45$139.80$116.30
12 Jul 2024$141.55$140.21$117.25
19 Jul 2024$137.95$140.13$118.30
26 Jul 2024$137.41$140.55$119.55
2 Aug 2024$139.52$140.46$121.05
9 Aug 2024$140.30$140.25$122.52
16 Aug 2024$150.30$140.46$124.26
23 Aug 2024$153.99$141.37$126.08
30 Aug 2024$150.92$142.57$127.82
6 Sep 2024$149.98$143.21$128.94
13 Sep 2024$163.56$144.89$130.37
20 Sep 2024$164.00$147.45$131.91
27 Sep 2024$163.08$149.89$133.33
4 Oct 2024$160.69$151.88$134.67
11 Oct 2024$160.85$153.96$136.01
18 Oct 2024$161.97$156.53$137.45
25 Oct 2024$156.99$158.08$138.78
1 Nov 2024$141.59$157.78$139.80
8 Nov 2024$149.66$157.15$140.87
15 Nov 2024$160.33$157.78$142.07
22 Nov 2024$165.51$158.31$143.32
29 Nov 2024$166.17$158.53$144.34
6 Dec 2024$160.25$158.52$145.36
13 Dec 2024$152.73$157.84$146.07
20 Dec 2024$151.85$156.90$146.53
27 Dec 2024$154.30$156.21$146.88
3 Jan 2025$152.82$155.32$147.15
10 Jan 2025$153.40$154.79$147.48
17 Jan 2025$166.24$156.52$148.13
24 Jan 2025$170.28$158.21$148.85
31 Jan 2025$176.20$160.02$149.93
7 Feb 2025$173.58$161.45$151.10
14 Feb 2025$157.42$161.92$152.01
21 Feb 2025$142.40$160.90$152.23
28 Feb 2025$147.88$159.93$152.43
7 Mar 2025$147.02$159.29$152.55
14 Mar 2025$143.45$158.45$152.75
21 Mar 2025$148.15$158.23$152.83
28 Mar 2025$150.22$157.56$153.02
4 Apr 2025$149.49$156.02$153.29
11 Apr 2025$155.51$153.68$153.50
17 Apr 2025$140.03$151.11$153.59
25 Apr 2025$139.56$147.54$153.58
2 May 2025$141.13$145.83$153.64
9 May 2025$143.76$145.74$153.74
16 May 2025$145.41$145.83$153.83
23 May 2025$138.19$145.41$153.94
30 May 2025$136.26$144.56$153.90
6 Jun 2025$137.90$143.22$153.58
13 Jun 2025$136.12$141.75$153.22
20 Jun 2025$136.94$140.82$152.90
27 Jun 2025$141.67$139.65$152.64
3 Jul 2025$142.56$140.13$152.36
11 Jul 2025$142.55$140.42$151.84
18 Jul 2025$141.16$140.45$151.32
25 Jul 2025$145.17$140.59$150.92
1 Aug 2025$138.48$140.49$150.54
8 Aug 2025$129.50$139.91$149.80
15 Aug 2025$135.38$139.62$149.10
22 Aug 2025$140.36$139.52$148.83
29 Aug 2025$137.76$139.59$148.58
5 Sep 2025$137.87$139.43$148.19
12 Sep 2025$133.17$138.53$147.53
19 Sep 2025$130.16$137.23$146.62
26 Sep 2025$130.80$136.20$145.85
3 Oct 2025$131.16$134.94$145.28
10 Oct 2025$123.99$133.26$144.74
17 Oct 2025$125.88$132.34$144.04
24 Oct 2025$129.19$132.00$143.48
31 Oct 2025$119.02$130.86$142.65
7 Nov 2025$123.69$129.17$141.48
14 Nov 2025$121.55$127.70$140.19
21 Nov 2025$120.25$125.99$138.71
28 Nov 2025$119.68$125.22$137.65
5 Dec 2025$117.39$123.89$136.65
12 Dec 2025$121.35$122.58$136.02
19 Dec 2025$115.20$121.45$135.40
26 Dec 2025$113.98$120.63$134.76
2 Jan 2026$114.51$119.59$134.12
9 Jan 2026$111.45$117.95$133.19
16 Jan 2026$104.74$116.47$132.04
23 Jan 2026$108.12$115.28$131.16
30 Jan 2026$109.34$113.84$130.06
6 Feb 2026$140.83$115.67$129.97
13 Feb 2026$148.95$118.08$130.07
20 Feb 2026$150.73$120.60$130.22
27 Feb 2026$156.30$123.87$130.43
6 Mar 2026$150.76$127.42$130.65
13 Mar 2026$150.72$131.27$130.95
20 Mar 2026$149.31$134.83$131.28
27 Mar 2026$154.43$139.42$131.70
2 Apr 2026$145.58$143.04$131.96
10 Apr 2026$150.05$147.30$132.27
17 Apr 2026$147.91$150.04$132.42
24 Apr 2026$151.85$150.98$132.64
1 May 2026$151.65$151.27$132.89
8 May 2026$198.65$154.17$133.78
15 May 2026$199.74$158.62$135.10
22 May 2026$198.52$163.13$136.61
29 May 2026$194.36$166.82$137.92
5 Jun 2026$192.16$170.76$139.34
12 Jun 2026$208.66$175.44$140.89
18 Jun 2026$207.91$180.31$142.33
26 Jun 2026$217.04$186.66$144.25
2 Jul 2026$234.91$192.86$146.13
10 Jul 2026$232.80$200.93$148.69
17 Jul 2026$236.97$208.94$151.26
24 Jul 2026$235.44$212.64$153.84
31 Jul 2026$240.09$216.86$156.65
7 Aug 2026$183.77$217.47$158.56
14 Aug 2026$180.06$216.24$159.86
21 Aug 2026$173.82$214.40$161.20
28 Aug 2026$180.68$211.44$162.63
4 Sep 2026$183.99$208.28$164.08
11 Sep 2026$181.55$205.06$165.37
18 Sep 2026$183.86$200.58$167.08
25 Sep 2026$178.47$195.29$168.64
2 Oct 2026$178.69$189.47$170.08
9 Oct 2026$179.25$183.49$171.62
16 Oct 2026$187.31$180.49$173.37
23 Oct 2026$183.64$180.53$175.07
30 Oct 2026$187.50$181.40$177.01
4 Nov 2026$192.66$182.05$178.24
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.

  • Price $192.66
  • 50-day avg $182.05
  • 200-day avg $178.24
Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.
WeekPrice50-day avg200-day avg
29 Oct 2021$103.24$120.47$117.66
12 Nov 2021$105.81$115.44$117.04
26 Nov 2021$97.29$111.06$116.58
10 Dec 2021$105.81$107.04$116.49
23 Dec 2021$111.42$105.87$116.56
7 Jan 2022$111.59$105.90$116.77
21 Jan 2022$109.39$106.94$117.00
4 Feb 2022$109.34$108.18$116.95
18 Feb 2022$115.49$111.12$116.77
4 Mar 2022$110.06$112.30$116.22
18 Mar 2022$113.59$111.96$115.74
1 Apr 2022$114.15$112.06$115.33
14 Apr 2022$121.45$113.62$115.17
29 Apr 2022$108.37$114.02$114.82
13 May 2022$100.05$112.33$114.09
27 May 2022$97.78$109.34$112.44
10 Jun 2022$93.16$106.13$110.80
24 Jun 2022$77.50$100.32$108.70
8 Jul 2022$83.12$93.77$106.86
22 Jul 2022$87.10$89.35$105.15
5 Aug 2022$85.68$86.91$103.80
19 Aug 2022$93.21$85.90$102.81
2 Sep 2022$87.80$86.38$101.97
16 Sep 2022$92.82$88.34$101.61
30 Sep 2022$82.77$88.74$100.83
14 Oct 2022$89.39$89.31$99.79
28 Oct 2022$70.54$89.37$98.64
11 Nov 2022$71.90$85.33$96.57
25 Nov 2022$73.92$81.72$94.82
9 Dec 2022$74.34$78.90$92.77
23 Dec 2022$73.76$76.05$90.85
6 Jan 2023$81.05$73.63$89.44
20 Jan 2023$80.32$74.13$87.89
3 Feb 2023$85.48$76.50$86.01
17 Feb 2023$83.93$78.59$84.58
3 Mar 2023$82.01$80.15$83.62
17 Mar 2023$76.77$80.76$82.69
31 Mar 2023$81.11$80.46$81.88
14 Apr 2023$83.96$80.93$81.91
28 Apr 2023$90.36$81.35$82.09
12 May 2023$93.72$83.18$82.41
26 May 2023$94.28$87.22$82.98
9 Jun 2023$97.48$90.86$83.22
23 Jun 2023$97.73$93.67$83.64
7 Jul 2023$103.89$96.35$83.97
21 Jul 2023$102.78$99.24$84.88
4 Aug 2023$108.81$100.11$85.57
18 Aug 2023$101.56$102.20$86.47
1 Sep 2023$102.99$102.98$88.09
15 Sep 2023$98.33$102.70$89.27
29 Sep 2023$94.53$101.58$90.51
13 Oct 2023$73.20$98.53$91.17
27 Oct 2023$76.77$92.64$91.22
10 Nov 2023$82.99$88.29$91.27
24 Nov 2023$99.26$87.84$91.80
8 Dec 2023$107.58$88.68$92.80
22 Dec 2023$104.33$92.22$94.08
5 Jan 2024$107.24$96.64$95.23
19 Jan 2024$104.76$101.95$96.54
2 Feb 2024$111.21$105.53$97.75
16 Feb 2024$122.22$108.27$99.14
1 Mar 2024$126.92$111.54$100.57
15 Mar 2024$136.65$117.51$102.44
28 Mar 2024$138.05$122.72$104.18
12 Apr 2024$130.42$128.22$105.99
26 Apr 2024$133.51$131.75$107.44
10 May 2024$137.52$134.53$109.15
24 May 2024$138.54$135.23$110.76
7 Jun 2024$143.18$136.78$112.59
21 Jun 2024$141.38$137.98$114.40
5 Jul 2024$136.45$139.80$116.30
19 Jul 2024$137.95$140.13$118.30
2 Aug 2024$139.52$140.46$121.05
16 Aug 2024$150.30$140.46$124.26
30 Aug 2024$150.92$142.57$127.82
13 Sep 2024$163.56$144.89$130.37
27 Sep 2024$163.08$149.89$133.33
11 Oct 2024$160.85$153.96$136.01
25 Oct 2024$156.99$158.08$138.78
8 Nov 2024$149.66$157.15$140.87
22 Nov 2024$165.51$158.31$143.32
6 Dec 2024$160.25$158.52$145.36
20 Dec 2024$151.85$156.90$146.53
3 Jan 2025$152.82$155.32$147.15
17 Jan 2025$166.24$156.52$148.13
31 Jan 2025$176.20$160.02$149.93
14 Feb 2025$157.42$161.92$152.01
28 Feb 2025$147.88$159.93$152.43
14 Mar 2025$143.45$158.45$152.75
28 Mar 2025$150.22$157.56$153.02
11 Apr 2025$155.51$153.68$153.50
25 Apr 2025$139.56$147.54$153.58
9 May 2025$143.76$145.74$153.74
23 May 2025$138.19$145.41$153.94
6 Jun 2025$137.90$143.22$153.58
20 Jun 2025$136.94$140.82$152.90
3 Jul 2025$142.56$140.13$152.36
18 Jul 2025$141.16$140.45$151.32
1 Aug 2025$138.48$140.49$150.54
15 Aug 2025$135.38$139.62$149.10
29 Aug 2025$137.76$139.59$148.58
12 Sep 2025$133.17$138.53$147.53
26 Sep 2025$130.80$136.20$145.85
10 Oct 2025$123.99$133.26$144.74
24 Oct 2025$129.19$132.00$143.48
7 Nov 2025$123.69$129.17$141.48
21 Nov 2025$120.25$125.99$138.71
5 Dec 2025$117.39$123.89$136.65
19 Dec 2025$115.20$121.45$135.40
2 Jan 2026$114.51$119.59$134.12
16 Jan 2026$104.74$116.47$132.04
30 Jan 2026$109.34$113.84$130.06
13 Feb 2026$148.95$118.08$130.07
27 Feb 2026$156.30$123.87$130.43
13 Mar 2026$150.72$131.27$130.95
27 Mar 2026$154.43$139.42$131.70
10 Apr 2026$150.05$147.30$132.27
24 Apr 2026$151.85$150.98$132.64
8 May 2026$198.65$154.17$133.78
22 May 2026$198.52$163.13$136.61
5 Jun 2026$192.16$170.76$139.34
18 Jun 2026$207.91$180.31$142.33
2 Jul 2026$234.91$192.86$146.13
17 Jul 2026$236.97$208.94$151.26
31 Jul 2026$240.09$216.86$156.65
14 Aug 2026$180.06$216.24$159.86
28 Aug 2026$180.68$211.44$162.63
11 Sep 2026$181.55$205.06$165.37
25 Sep 2026$178.47$195.29$168.64
9 Oct 2026$179.25$183.49$171.62
23 Oct 2026$183.64$180.53$175.07
4 Nov 2026$192.66$182.05$178.24
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.

  • Price $192.66
  • 50-day avg $182.05
  • 200-day avg $178.24
Nov 2026: $192.66, 8.1% above its 200-day average. The price has been rising for 21 weeks.
WeekPrice50-day avg200-day avg
28 Oct 2016$55.16$63.47–
18 Nov 2016$61.52$61.96–
9 Dec 2016$66.49$61.64–
30 Dec 2016$64.20$62.03–
20 Jan 2017$63.02$63.60–
10 Feb 2017$64.75$64.48–
3 Mar 2017$70.00$65.33–
24 Mar 2017$66.77$66.25–
13 Apr 2017$67.78$67.36–
5 May 2017$65.45$68.03$65.78
26 May 2017$64.75$66.91$64.95
16 Jun 2017$66.17$66.42$64.90
7 Jul 2017$63.42$65.42$64.92
28 Jul 2017$65.47$64.93$64.91
18 Aug 2017$56.23$62.78$64.76
8 Sep 2017$58.31$60.60$64.59
29 Sep 2017$59.39$59.12$64.22
20 Oct 2017$59.35$57.93$63.67
10 Nov 2017$55.00$58.69$63.34
1 Dec 2017$61.11$58.04$62.81
22 Dec 2017$71.98$61.40$62.82
12 Jan 2018$79.13$65.40$63.31
2 Feb 2018$75.65$71.55$64.06
23 Feb 2018$73.18$74.80$64.46
16 Mar 2018$68.53$74.79$64.94
6 Apr 2018$63.03$71.23$64.92
27 Apr 2018$63.22$67.49$64.86
18 May 2018$68.12$65.34$64.91
8 Jun 2018$71.05$65.34$65.69
29 Jun 2018$69.44$67.76$66.72
20 Jul 2018$69.98$69.63$67.49
10 Aug 2018$71.79$70.89$68.54
31 Aug 2018$69.29$71.22$69.52
21 Sep 2018$69.92$70.81$70.30
12 Oct 2018$68.93$71.14$70.40
2 Nov 2018$67.66$69.62$69.73
23 Nov 2018$59.66$68.57$68.92
14 Dec 2018$58.02$65.95$68.13
4 Jan 2019$54.00$61.10$66.91
25 Jan 2019$57.09$57.72$66.31
15 Feb 2019$59.10$55.77$65.83
8 Mar 2019$49.95$55.61$65.13
29 Mar 2019$54.29$55.51$63.98
18 Apr 2019$52.23$54.98$62.80
10 May 2019$52.11$54.00$61.61
31 May 2019$43.42$52.70$59.96
21 Jun 2019$53.09$50.95$58.25
12 Jul 2019$56.90$51.37$57.31
2 Aug 2019$60.10$53.28$56.32
23 Aug 2019$54.70$56.64$55.61
13 Sep 2019$61.86$57.96$55.15
4 Oct 2019$56.00$58.34$54.94
25 Oct 2019$57.83$57.66$55.32
15 Nov 2019$70.83$60.22$55.96
6 Dec 2019$72.70$63.65$56.99
27 Dec 2019$74.75$68.50$58.34
17 Jan 2020$79.47$73.32$59.91
7 Feb 2020$81.34$76.31$61.82
28 Feb 2020$77.62$79.45$63.86
20 Mar 2020$64.99$79.87$66.00
9 Apr 2020$74.82$77.72$67.53
1 May 2020$76.51$75.54$69.05
22 May 2020$76.81$75.55$70.58
12 Jun 2020$78.25$78.16$72.28
2 Jul 2020$81.05$79.47$73.62
24 Jul 2020$87.33$81.01$75.61
14 Aug 2020$82.17$82.63$77.67
4 Sep 2020$87.06$84.64$79.19
25 Sep 2020$83.90$86.29$80.19
16 Oct 2020$90.78$86.33$81.17
6 Nov 2020$98.62$88.07$82.14
27 Nov 2020$109.88$93.91$83.96
18 Dec 2020$115.36$101.58$86.08
8 Jan 2021$123.89$108.82$89.02
29 Jan 2021$117.37$114.71$92.25
19 Feb 2021$102.07$114.58$94.49
12 Mar 2021$108.44$111.89$96.35
1 Apr 2021$105.44$108.78$98.25
23 Apr 2021$113.60$107.25$100.55
14 May 2021$125.41$112.56$103.23
4 Jun 2021$120.28$116.27$105.83
25 Jun 2021$121.67$120.33$108.43
16 Jul 2021$119.37$122.06$110.88
6 Aug 2021$133.17$121.71$113.50
27 Aug 2021$130.81$124.90$116.41
17 Sep 2021$121.55$126.46$117.65
8 Oct 2021$113.22$125.85$118.17
29 Oct 2021$103.24$120.47$117.66
19 Nov 2021$99.55$112.74$116.79
10 Dec 2021$105.81$107.04$116.49
31 Dec 2021$113.76$105.90$116.67
21 Jan 2022$109.39$106.94$117.00
11 Feb 2022$111.62$109.60$116.90
4 Mar 2022$110.06$112.30$116.22
25 Mar 2022$114.38$111.84$115.53
14 Apr 2022$121.45$113.62$115.17
6 May 2022$102.96$113.30$114.51
27 May 2022$97.78$109.34$112.44
17 Jun 2022$89.48$103.66$109.77
8 Jul 2022$83.12$93.77$106.86
29 Jul 2022$84.16$87.79$104.46
19 Aug 2022$93.21$85.90$102.81
9 Sep 2022$92.62$87.24$101.76
30 Sep 2022$82.77$88.74$100.83
21 Oct 2022$89.99$89.41$99.19
11 Nov 2022$71.90$85.33$96.57
2 Dec 2022$74.34$79.93$93.77
23 Dec 2022$73.76$76.05$90.85
13 Jan 2023$79.03$73.35$88.58
3 Feb 2023$85.48$76.50$86.01
24 Feb 2023$82.31$79.29$84.12
17 Mar 2023$76.77$80.76$82.69
6 Apr 2023$82.47$80.73$81.80
28 Apr 2023$90.36$81.35$82.09
19 May 2023$100.33$85.18$82.76
9 Jun 2023$97.48$90.86$83.22
30 Jun 2023$100.47$95.08$83.78
21 Jul 2023$102.78$99.24$84.88
11 Aug 2023$108.35$101.68$86.05
1 Sep 2023$102.99$102.98$88.09
22 Sep 2023$98.71$102.46$89.97
13 Oct 2023$73.20$98.53$91.17
3 Nov 2023$79.45$90.25$91.19
24 Nov 2023$99.26$87.84$91.80
15 Dec 2023$105.69$90.07$93.43
5 Jan 2024$107.24$96.64$95.23
26 Jan 2024$107.17$104.09$97.11
16 Feb 2024$122.22$108.27$99.14
8 Mar 2024$135.17$114.30$101.39
28 Mar 2024$138.05$122.72$104.18
19 Apr 2024$127.82$129.88$106.70
10 May 2024$137.52$134.53$109.15
31 May 2024$147.12$135.91$111.54
21 Jun 2024$141.38$137.98$114.40
12 Jul 2024$141.55$140.21$117.25
2 Aug 2024$139.52$140.46$121.05
23 Aug 2024$153.99$141.37$126.08
13 Sep 2024$163.56$144.89$130.37
4 Oct 2024$160.69$151.88$134.67
25 Oct 2024$156.99$158.08$138.78
15 Nov 2024$160.33$157.78$142.07
6 Dec 2024$160.25$158.52$145.36
27 Dec 2024$154.30$156.21$146.88
17 Jan 2025$166.24$156.52$148.13
7 Feb 2025$173.58$161.45$151.10
28 Feb 2025$147.88$159.93$152.43
21 Mar 2025$148.15$158.23$152.83
11 Apr 2025$155.51$153.68$153.50
2 May 2025$141.13$145.83$153.64
23 May 2025$138.19$145.41$153.94
13 Jun 2025$136.12$141.75$153.22
3 Jul 2025$142.56$140.13$152.36
25 Jul 2025$145.17$140.59$150.92
15 Aug 2025$135.38$139.62$149.10
5 Sep 2025$137.87$139.43$148.19
26 Sep 2025$130.80$136.20$145.85
17 Oct 2025$125.88$132.34$144.04
7 Nov 2025$123.69$129.17$141.48
28 Nov 2025$119.68$125.22$137.65
19 Dec 2025$115.20$121.45$135.40
9 Jan 2026$111.45$117.95$133.19
30 Jan 2026$109.34$113.84$130.06
20 Feb 2026$150.73$120.60$130.22
13 Mar 2026$150.72$131.27$130.95
2 Apr 2026$145.58$143.04$131.96
24 Apr 2026$151.85$150.98$132.64
15 May 2026$199.74$158.62$135.10
5 Jun 2026$192.16$170.76$139.34
26 Jun 2026$217.04$186.66$144.25
17 Jul 2026$236.97$208.94$151.26
7 Aug 2026$183.77$217.47$158.56
28 Aug 2026$180.68$211.44$162.63
18 Sep 2026$183.86$200.58$167.08
9 Oct 2026$179.25$183.49$171.62
30 Oct 2026$187.50$181.40$177.01
4 Nov 2026$192.66$182.05$178.24
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Falling from Oct 2025 to Jan 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jun 2026 to Nov 2026.

Price stage: Rising from Nov 2023 to Feb 2025; Sideways from Feb 2025 to Aug 2025; Falling from Sep 2025 to Jan 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jun 2026 to Nov 2026.

Price stage: Sideways from Oct 2021 to Apr 2022; Falling from Apr 2022 to Mar 2023; Sideways from Apr 2023 to Aug 2023; Rising in Sep 2023; Sideways from Oct 2023 to Nov 2023; Rising from Nov 2023 to Feb 2025; Sideways from Feb 2025 to Aug 2025; Falling from Sep 2025 to Jan 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jun 2026 to Nov 2026.

Price stage: Sideways from Dec 2017 to Apr 2018; Rising from May 2018 to Aug 2018; Sideways from Aug 2018 to Jan 2019; Falling from Feb 2019 to Aug 2019; Sideways from Sep 2019 to Dec 2019; Rising from Jan 2020 to Sep 2021; Sideways from Oct 2021 to Apr 2022; Falling from May 2022 to Mar 2023; Sideways from Apr 2023 to Nov 2023; Rising from Nov 2023 to Apr 2025; Sideways from May 2025 to Aug 2025; Falling from Sep 2025 to Jan 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jun 2026 to Nov 2026.

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?

Ahead in 239 of 527 weeks

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
8 Jul 2016no S&P 500 reading
15 Jul 2016no S&P 500 reading
22 Jul 2016no S&P 500 reading
29 Jul 2016no S&P 500 reading
5 Aug 2016no S&P 500 reading
12 Aug 2016no S&P 500 reading
19 Aug 2016no S&P 500 reading
26 Aug 2016no S&P 500 reading
2 Sep 2016no S&P 500 reading
9 Sep 2016no S&P 500 reading
16 Sep 2016no S&P 500 reading
23 Sep 2016no S&P 500 reading
30 Sep 2016no S&P 500 reading
7 Oct 2016−19.9%
14 Oct 2016−17.9%
21 Oct 2016−20.3%
28 Oct 2016−26.8%
4 Nov 2016−19.4%
11 Nov 2016−13.0%
18 Nov 2016−4.6%
25 Nov 2016−2.5%
2 Dec 2016−1.4%
9 Dec 2016−1.7%
16 Dec 2016−4.7%
23 Dec 2016−6.5%
30 Dec 2016−6.2%
6 Jan 2017−1.9%
13 Jan 2017−4.8%
20 Jan 2017−2.6%
27 Jan 2017+9.3%
3 Feb 2017+1.4%
10 Feb 2017+1.8%
17 Feb 2017+1.2%
24 Feb 2017+2.1%
3 Mar 2017+0.5%
10 Mar 2017−1.8%
17 Mar 2017−0.9%
24 Mar 2017−1.2%
31 Mar 2017+0.4%
7 Apr 2017−1.6%
13 Apr 2017+3.6%
21 Apr 2017+4.0%
28 Apr 2017+2.9%
5 May 2017−4.3%
12 May 2017−0.3%
19 May 2017−4.9%
26 May 2017−8.3%
2 Jun 2017−7.5%
9 Jun 2017−8.4%
16 Jun 2017−4.8%
23 Jun 2017−6.8%
30 Jun 2017−7.3%
7 Jul 2017−8.3%
14 Jul 2017−10.2%
21 Jul 2017−8.2%
28 Jul 2017−8.8%
4 Aug 2017−15.1%
11 Aug 2017−17.3%
18 Aug 2017−14.8%
25 Aug 2017−12.8%
1 Sep 2017−14.4%
8 Sep 2017−10.9%
15 Sep 2017−12.6%
22 Sep 2017−14.0%
29 Sep 2017−12.2%
6 Oct 2017−10.7%
13 Oct 2017−19.2%
20 Oct 2017−13.9%
27 Oct 2017−9.8%
3 Nov 2017−0.6%
10 Nov 2017−8.5%
17 Nov 2017−8.6%
24 Nov 2017−6.6%
1 Dec 2017−1.1%
8 Dec 2017+8.4%
15 Dec 2017+11.3%
22 Dec 2017+18.0%
29 Dec 2017+15.4%
5 Jan 2018+18.8%
12 Jan 2018+35.6%
19 Jan 2018+23.4%
26 Jan 2018+16.6%
2 Feb 2018+19.7%
9 Feb 2018+31.4%
16 Feb 2018+28.2%
23 Feb 2018+22.5%
2 Mar 2018+15.9%
9 Mar 2018+2.0%
16 Mar 2018−5.7%
23 Mar 2018−6.2%
29 Mar 2018−7.3%
6 Apr 2018−11.5%
13 Apr 2018−15.9%
20 Apr 2018−14.0%
27 Apr 2018−13.1%
4 May 2018−8.8%
11 May 2018−13.9%
18 May 2018−6.9%
25 May 2018−6.3%
1 Jun 2018−8.4%
8 Jun 2018−1.7%
15 Jun 2018+6.1%
22 Jun 2018+4.2%
29 Jun 2018+2.2%
6 Jul 2018+5.4%
13 Jul 2018+8.7%
20 Jul 2018+4.9%
27 Jul 2018+4.6%
3 Aug 2018+5.7%
10 Aug 2018+5.0%
17 Aug 2018+1.4%
24 Aug 2018+1.6%
31 Aug 2018−2.8%
7 Sep 2018−8.7%
14 Sep 2018−8.6%
21 Sep 2018−9.1%
28 Sep 2018−4.0%
5 Oct 2018−1.9%
12 Oct 2018−2.7%
19 Oct 2018−2.1%
26 Oct 2018−0.9%
2 Nov 2018−5.1%
9 Nov 2018−1.0%
16 Nov 2018−9.9%
23 Nov 2018−9.6%
30 Nov 2018+0.4%
7 Dec 2018−4.0%
14 Dec 2018−7.6%
21 Dec 2018−11.2%
28 Dec 2018−14.9%
4 Jan 2019−12.7%
11 Jan 2019−12.5%
18 Jan 2019−11.7%
25 Jan 2019−12.4%
1 Feb 2019−16.1%
8 Feb 2019−16.8%
15 Feb 2019−6.7%
22 Feb 2019−7.6%
1 Mar 2019−15.4%
8 Mar 2019−19.4%
15 Mar 2019−15.7%
22 Mar 2019−7.5%
29 Mar 2019−6.2%
5 Apr 2019−10.7%
12 Apr 2019−14.8%
18 Apr 2019−17.8%
26 Apr 2019−13.0%
3 May 2019−7.7%
10 May 2019−13.7%
17 May 2019−19.8%
24 May 2019−20.3%
31 May 2019−22.1%
7 Jun 2019−9.3%
14 Jun 2019−11.5%
21 Jun 2019−7.1%
28 Jun 2019−0.1%
5 Jul 2019+0.7%
12 Jul 2019+0.7%
19 Jul 2019+4.8%
26 Jul 2019+3.9%
2 Aug 2019+5.9%
9 Aug 2019+13.3%
16 Aug 2019+16.4%
23 Aug 2019+14.3%
30 Aug 2019+23.6%
6 Sep 2019+20.9%
13 Sep 2019+22.5%
20 Sep 2019+11.6%
27 Sep 2019−0.7%
4 Oct 2019−2.5%
11 Oct 2019+0.6%
18 Oct 2019+4.4%
25 Oct 2019−2.5%
1 Nov 2019−5.6%
8 Nov 2019+11.1%
15 Nov 2019+14.6%
22 Nov 2019+23.3%
29 Nov 2019+19.8%
6 Dec 2019+16.8%
13 Dec 2019+12.1%
20 Dec 2019+15.2%
27 Dec 2019+23.4%
3 Jan 2020+24.5%
10 Jan 2020+24.6%
17 Jan 2020+24.0%
24 Jan 2020+34.8%
31 Jan 2020+29.1%
7 Feb 2020+8.9%
14 Feb 2020+13.1%
21 Feb 2020+8.8%
28 Feb 2020+13.9%
6 Mar 2020+18.1%
13 Mar 2020+19.6%
20 Mar 2020+16.8%
27 Mar 2020+19.3%
3 Apr 2020+10.3%
9 Apr 2020+13.1%
17 Apr 2020+12.0%
24 Apr 2020+2.9%
1 May 2020+7.9%
8 May 2020+11.3%
15 May 2020+7.4%
22 May 2020+2.7%
29 May 2020+1.6%
5 Jun 2020+0.5%
12 Jun 2020−9.9%
19 Jun 2020−12.5%
26 Jun 2020−15.0%
2 Jul 2020−2.1%
10 Jul 2020−5.6%
17 Jul 2020−3.3%
24 Jul 2020+4.6%
31 Jul 2020−1.2%
7 Aug 2020−12.4%
14 Aug 2020−14.0%
21 Aug 2020−1.9%
28 Aug 2020−7.8%
4 Sep 2020−8.7%
11 Sep 2020+2.7%
18 Sep 2020+2.6%
25 Sep 2020+1.5%
2 Oct 2020−2.9%
9 Oct 2020−1.0%
16 Oct 2020−1.3%
23 Oct 2020−3.5%
30 Oct 2020−1.3%
6 Nov 2020+15.1%
13 Nov 2020+28.2%
20 Nov 2020+21.9%
27 Nov 2020+22.7%
4 Dec 2020+17.6%
11 Dec 2020+13.4%
18 Dec 2020+20.5%
24 Dec 2020+25.0%
31 Dec 2020+27.3%
8 Jan 2021+31.1%
15 Jan 2021+22.6%
22 Jan 2021+20.6%
29 Jan 2021+22.8%
5 Feb 2021+0.0%
12 Feb 2021−14.7%
19 Feb 2021−16.8%
26 Feb 2021−11.6%
5 Mar 2021−7.2%
12 Mar 2021−7.5%
19 Mar 2021−10.3%
26 Mar 2021−12.8%
1 Apr 2021−17.3%
9 Apr 2021−19.9%
16 Apr 2021−15.8%
23 Apr 2021−13.9%
30 Apr 2021−13.5%
7 May 2021+7.3%
14 May 2021+13.4%
21 May 2021+13.7%
28 May 2021+7.1%
4 Jun 2021+3.8%
11 Jun 2021+5.1%
18 Jun 2021+4.2%
25 Jun 2021+4.1%
2 Jul 2021+7.9%
9 Jul 2021+6.2%
16 Jul 2021+2.2%
23 Jul 2021+0.6%
30 Jul 2021−1.9%
6 Aug 2021+0.2%
13 Aug 2021−3.2%
20 Aug 2021+1.4%
27 Aug 2021+1.8%
3 Sep 2021+2.7%
10 Sep 2021−4.3%
17 Sep 2021−6.4%
24 Sep 2021−4.6%
1 Oct 2021−4.6%
8 Oct 2021−7.8%
15 Oct 2021−9.4%
22 Oct 2021−7.1%
29 Oct 2021−18.9%
5 Nov 2021−23.8%
12 Nov 2021−23.6%
19 Nov 2021−30.7%
26 Nov 2021−27.6%
3 Dec 2021−25.3%
10 Dec 2021−19.7%
17 Dec 2021−17.9%
23 Dec 2021−13.9%
31 Dec 2021−12.1%
7 Jan 2022−7.9%
14 Jan 2022−0.6%
21 Jan 2022−2.0%
28 Jan 2022+10.5%
4 Feb 2022+4.2%
11 Feb 2022+11.2%
18 Feb 2022+23.4%
25 Feb 2022+22.4%
4 Mar 2022+16.0%
11 Mar 2022+14.7%
18 Mar 2022+11.7%
25 Mar 2022+6.5%
1 Apr 2022+5.0%
8 Apr 2022+13.4%
14 Apr 2022+10.2%
22 Apr 2022+4.6%
29 Apr 2022+5.1%
6 May 2022+2.5%
13 May 2022−1.6%
20 May 2022−8.0%
27 May 2022−9.5%
3 Jun 2022−7.1%
10 Jun 2022−8.1%
17 Jun 2022−3.5%
24 Jun 2022−18.4%
1 Jul 2022−11.4%
8 Jul 2022−18.7%
15 Jul 2022−17.6%
22 Jul 2022−14.6%
29 Jul 2022−22.3%
5 Aug 2022−17.3%
12 Aug 2022−13.9%
19 Aug 2022−9.6%
26 Aug 2022−6.9%
2 Sep 2022−4.7%
9 Sep 2022−4.9%
16 Sep 2022−1.7%
23 Sep 2022+17.0%
30 Sep 2022+5.9%
7 Oct 2022+11.5%
14 Oct 2022+11.7%
21 Oct 2022+8.6%
28 Oct 2022−10.6%
4 Nov 2022−8.9%
11 Nov 2022−15.6%
18 Nov 2022−18.0%
25 Nov 2022−15.9%
2 Dec 2022−19.1%
9 Dec 2022−16.5%
16 Dec 2022−21.4%
23 Dec 2022−18.6%
30 Dec 2022−16.9%
6 Jan 2023−14.0%
13 Jan 2023−23.0%
20 Jan 2023−16.5%
27 Jan 2023+10.8%
3 Feb 2023+11.9%
10 Feb 2023+13.2%
17 Feb 2023+16.0%
24 Feb 2023+12.8%
3 Mar 2023+11.0%
10 Mar 2023+2.3%
17 Mar 2023+4.3%
24 Mar 2023−0.2%
31 Mar 2023+1.6%
6 Apr 2023−3.7%
14 Apr 2023+2.7%
21 Apr 2023+3.0%
28 Apr 2023+8.8%
5 May 2023+3.4%
12 May 2023+11.9%
19 May 2023+16.8%
26 May 2023+8.6%
2 Jun 2023+14.5%
9 Jun 2023+19.1%
16 Jun 2023+14.5%
23 Jun 2023+18.9%
30 Jun 2023+15.6%
7 Jul 2023+18.8%
14 Jul 2023+14.6%
21 Jul 2023+9.8%
28 Jul 2023+2.0%
4 Aug 2023+14.7%
11 Aug 2023+7.3%
18 Aug 2023−3.0%
25 Aug 2023+2.0%
1 Sep 2023−1.1%
8 Sep 2023−5.6%
15 Sep 2023−0.2%
22 Sep 2023+1.6%
29 Sep 2023−2.3%
6 Oct 2023−11.7%
13 Oct 2023−25.5%
20 Oct 2023−17.7%
27 Oct 2023−13.9%
3 Nov 2023−24.3%
10 Nov 2023−22.3%
17 Nov 2023−8.6%
24 Nov 2023−4.8%
1 Dec 2023−0.5%
8 Dec 2023+9.3%
15 Dec 2023+1.6%
22 Dec 2023−4.4%
29 Dec 2023−0.4%
5 Jan 2024+10.8%
12 Jan 2024+38.6%
19 Jan 2024+20.6%
26 Jan 2024+20.9%
2 Feb 2024+26.3%
9 Feb 2024+18.6%
16 Feb 2024+16.3%
23 Feb 2024+14.7%
1 Mar 2024+10.0%
8 Mar 2024+14.5%
15 Mar 2024+20.7%
22 Mar 2024+18.5%
28 Mar 2024+21.7%
5 Apr 2024+13.8%
12 Apr 2024+12.4%
19 Apr 2024+19.4%
26 Apr 2024+20.3%
3 May 2024+17.5%
10 May 2024+21.3%
17 May 2024+8.4%
24 May 2024+6.4%
31 May 2024+13.1%
7 Jun 2024+1.6%
14 Jun 2024−3.2%
21 Jun 2024+1.0%
28 Jun 2024−3.7%
5 Jul 2024−4.9%
12 Jul 2024−1.1%
19 Jul 2024−2.9%
26 Jul 2024−4.2%
2 Aug 2024−0.5%
9 Aug 2024−0.3%
16 Aug 2024+2.8%
23 Aug 2024+5.0%
30 Aug 2024−4.3%
6 Sep 2024+3.6%
13 Sep 2024+12.3%
20 Sep 2024+11.6%
27 Sep 2024+12.7%
4 Oct 2024+14.5%
11 Oct 2024+10.1%
18 Oct 2024+10.9%
25 Oct 2024+7.9%
1 Nov 2024−5.7%
8 Nov 2024−5.6%
15 Nov 2024+1.0%
22 Nov 2024+1.5%
29 Nov 2024+3.2%
6 Dec 2024−5.6%
13 Dec 2024−14.1%
20 Dec 2024−11.4%
27 Dec 2024−9.5%
3 Jan 2025−8.2%
10 Jan 2025−4.8%
17 Jan 2025+0.4%
24 Jan 2025+3.5%
31 Jan 2025+19.1%
7 Feb 2025+15.6%
14 Feb 2025−5.9%
21 Feb 2025−14.7%
28 Feb 2025−9.6%
7 Mar 2025−3.0%
14 Mar 2025+0.8%
21 Mar 2025+2.2%
28 Mar 2025+4.0%
4 Apr 2025+12.5%
11 Apr 2025+9.4%
17 Apr 2025−3.9%
25 Apr 2025−8.6%
2 May 2025−14.1%
9 May 2025−11.1%
16 May 2025−5.1%
23 May 2025+0.5%
30 May 2025−7.1%
6 Jun 2025−10.2%
13 Jun 2025−11.2%
20 Jun 2025−12.9%
27 Jun 2025−16.4%
3 Jul 2025−28.4%
11 Jul 2025−25.1%
18 Jul 2025−18.4%
25 Jul 2025−11.7%
1 Aug 2025−11.6%
8 Aug 2025−22.8%
15 Aug 2025−15.2%
22 Aug 2025−9.9%
29 Aug 2025−8.3%
5 Sep 2025−8.0%
12 Sep 2025−12.3%
19 Sep 2025−16.6%
26 Sep 2025−15.3%
3 Oct 2025−15.0%
10 Oct 2025−17.7%
17 Oct 2025−16.7%
24 Oct 2025−17.3%
31 Oct 2025−23.8%
7 Nov 2025−9.8%
14 Nov 2025−14.6%
21 Nov 2025−16.5%
28 Nov 2025−19.1%
5 Dec 2025−20.8%
12 Dec 2025−12.6%
19 Dec 2025−14.0%
26 Dec 2025−17.2%
2 Jan 2026−14.8%
9 Jan 2026−16.4%
16 Jan 2026−20.9%
23 Jan 2026−18.1%
30 Jan 2026−9.6%
6 Feb 2026+10.9%
13 Feb 2026+21.1%
20 Feb 2026+20.7%
27 Feb 2026+30.2%
6 Mar 2026+30.4%
13 Mar 2026+27.1%
20 Mar 2026+34.3%
27 Mar 2026+43.6%
2 Apr 2026+31.1%
10 Apr 2026+36.7%
17 Apr 2026+38.5%
24 Apr 2026+36.9%
1 May 2026+34.6%
8 May 2026+34.3%
15 May 2026+25.7%
22 May 2026+23.6%
29 May 2026+14.1%
5 Jun 2026+17.8%
12 Jun 2026+26.4%
18 Jun 2026+24.1%
26 Jun 2026+25.6%
2 Jul 2026+47.8%
10 Jul 2026+44.0%
17 Jul 2026+55.5%
24 Jul 2026+51.5%
31 Jul 2026+54.7%
7 Aug 2026−12.3%
14 Aug 2026−14.9%
21 Aug 2026−15.1%
28 Aug 2026−8.7%
4 Sep 2026−8.7%
11 Sep 2026−16.0%
18 Sep 2026−13.6%
25 Sep 2026−23.6%
2 Oct 2026−27.3%
9 Oct 2026−26.1%
16 Oct 2026−23.6%
23 Oct 2026−24.8%
30 Oct 2026−23.1%
4 Nov 2026+5.7%
Each bar is one week, from 2016 to now (527 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 10 years the share price moved +147% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does DaVita pay?

DaVita Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.

Which stock lists is DaVita on?

DaVita is on one of our US lists: S&P 500 companies.

Is DaVita profitable?

DaVita Inc. earned $343 M of net profit in the Jun 2026 quarter, +24.7% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY25 profit was $1.1 B. Over 4 years profit has grown −2.9% a year on average. That is 9.7% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned $275 M.

For the full year, FY25 profit was $1.1 B (−13.8% on the year before).

FY25 profit $1.1 B (−13.8% on the year before), −2.9% a year over 4 years

  • Net profit $1.1 B
FY25 profit $1.1 B (−13.8% on the year before), −2.9% a year over 4 years
QuarterNet profit
FY21$1.2 B
FY22$782 M
FY23$957 M
FY24$1.3 B
FY25$1.1 B

Growth on a year earlier

  • Growth on a year earlier −13.8%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−35.5%
FY2322.4%
FY2430.7%
FY25−13.8%
Top: net profit each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $343 M (+24.7% on a year earlier), the 2nd quarter in a row of growth

  • Net profit (quarterly) $343 M
Jun 2026: $343 M (+24.7% on a year earlier), the 2nd quarter in a row of growth
QuarterNet profit (quarterly)
Sep 2023$309 M
Dec 2023$231 M
Mar 2024$306 M
Jun 2024$300 M
Sep 2024$296 M
Dec 2024$349 M
Mar 2025$232 M
Jun 2025$275 M
Sep 2025$240 M
Dec 2025$331 M
Mar 2026$275 M
Jun 2026$343 M

Growth on a year earlier

  • Growth on a year earlier 24.7%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 202387.8%
Dec 2023–
Mar 202479.3%
Jun 202421.7%
Sep 2024−4.4%
Dec 202451.5%
Mar 2025−24.1%
Jun 2025−8.2%
Sep 2025−18.8%
Dec 2025−5.2%
Mar 202618.4%
Jun 202624.7%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +5.2% on a year earlier and the margin moved +0.4 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +4.8% and revenue +6.5%. Profit and revenue are moving at about the same pace.

How much revenue does DaVita make, and is it growing?

DaVita Inc. reported $3.6 B of revenue in the Jun 2026 quarter, +5.2% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 4 years it has grown 4.1% a year on average. The last full year, FY25, came in at $13.6 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $14.0 B.

FY25 revenue was $13.6 B, +6.5% on the year before.

FY25 revenue $13.6 B (+6.5% on the year before), 4.1% a year over 4 years

  • Revenue $13.6 B
FY25 revenue $13.6 B (+6.5% on the year before), 4.1% a year over 4 years
QuarterRevenue
FY21$11.6 B
FY22$11.6 B
FY23$12.1 B
FY24$12.8 B
FY25$13.6 B

Growth on a year earlier

  • Growth on a year earlier 6.5%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−0.1%
FY234.6%
FY245.6%
FY256.5%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $3.6 B (+5.2% on a year earlier), the 10th quarter in a row of growth

  • Revenue (quarterly) $3.6 B
Jun 2026: $3.6 B (+5.2% on a year earlier), the 10th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$3.1 B
Dec 2023$3.1 B
Mar 2024$3.1 B
Jun 2024$3.2 B
Sep 2024$3.3 B
Dec 2024$3.3 B
Mar 2025$3.2 B
Jun 2025$3.4 B
Sep 2025$3.4 B
Dec 2025$3.6 B
Mar 2026$3.4 B
Jun 2026$3.6 B

Growth on a year earlier

  • Growth on a year earlier 5.2%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 20235.9%
Dec 2023–
Mar 20246.9%
Jun 20246.2%
Sep 20244.6%
Dec 20244.7%
Mar 20255%
Jun 20256.1%
Sep 20254.8%
Dec 20259.9%
Mar 20266%
Jun 20265.2%
Top: revenue each quarter, $ B. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +6.5% on average, against 4.1% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +6.4%, against +5.8% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +3.2%, against +1.9% a year (stabilising).

How much of every $100 of sales does DaVita keep?

DaVita Inc.'s operating margin was 16.1% in the Jun 2026 quarter, 0.4 percentage points higher than the same quarter a year ago. Across 5 years it has been between 11.3% and 15.3%. The latest quarter is above every full year in that period.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +0.4 percentage points on the year while gross margin changed −0.4 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

FY25: 14.9%, within a range of 11.3% to 15.3% over 5 years

  • Operating margin 14.9%
FY25: 14.9%, within a range of 11.3% to 15.3% over 5 years
QuarterOperating margin
FY2115.2%
FY2211.3%
FY2313.2%
FY2415.3%
FY2514.9%

Change on the year before (points)

  • Change on the year before (points) −0.4 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−3.9 pts
FY23+1.9 pts
FY24+2.1 pts
FY25−0.4 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 16.1% (+0.4 points on a year earlier)

  • Operating margin 16.1%
Jun 2026: operating margin 16.1% (+0.4 points on a year earlier)
QuarterOperating margin
Sep 202315.7%
Dec 202310%
Mar 202414.4%
Jun 202415.7%
Sep 202416.3%
Dec 202414.6%
Mar 202513.4%
Jun 202515.7%
Sep 202514.8%
Dec 202515.2%
Mar 202613.9%
Jun 202616.1%

Change on a year earlier (points)

  • Change on a year earlier (points) +0.4 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023+5.4 pts
Dec 2023–
Mar 2024+3.8 pts
Jun 2024+2.5 pts
Sep 2024+0.6 pts
Dec 2024+4.6 pts
Mar 2025−1.0 pts
Jun 20250.0 pts
Sep 2025−1.5 pts
Dec 2025+0.6 pts
Mar 2026+0.5 pts
Jun 2026+0.4 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is DaVita's profit turning into cash?

Over the last 3 years, 182% of DaVita Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $1.9 B of operating cash against $1.1 B of profit. After $576 M of spending on assets, $1.3 B was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $1.9 B against profit $1.1 B; 182% of 3 years' profit came in as cash

  • Operating cash $1.9 B
  • Net profit $1.1 B
  • Free cash $1.3 B
FY25: operating cash $1.9 B against profit $1.1 B; 182% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$1.9 B$1.2 B$1.3 B
FY22$1.6 B$782 M$961 M
FY23$2.1 B$957 M$1.5 B
FY24$2.0 B$1.3 B$1.5 B
FY25$1.9 B$1.1 B$1.3 B
Operating cash flow and net profit each year, $ B. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $490 M = 143% of the quarter's profit

  • Operating cash (quarterly) $490 M
Jun 2026: operating cash $490 M = 143% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$661 M
Dec 2023$485 M
Mar 2024−$135 M
Jun 2024$799 M
Sep 2024$810 M
Dec 2024$548 M
Mar 2025$180 M
Jun 2025$324 M
Sep 2025$842 M
Dec 2025$541 M
Mar 2026$321 M
Jun 2026$490 M

Operating cash as % of profit

  • Operating cash as % of profit 143%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023214%
Dec 2023210%
Mar 2024−44%
Jun 2024267%
Sep 2024274%
Dec 2024157%
Mar 202578%
Jun 2025118%
Sep 2025350%
Dec 2025163%
Mar 2026117%
Jun 2026143%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does DaVita's cash go?

DaVita Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1.7 B on assets over the last 3 years. Averaged over those years that is 4.2% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $1.7 B over the last 3 years.

FY25: capex $576 M, steady spending

  • Capex $576 M
FY25: capex $576 M, steady spending
QuarterCapex
FY21$641 M
FY22$603 M
FY23$568 M
FY24$555 M
FY25$576 M
Capital spending each year, $ M.

Jun 2026: capex $170 M in the quarter

  • Capex (quarterly) $170 M
Jun 2026: capex $170 M in the quarter
QuarterCapex (quarterly)
Sep 2023$137 M
Dec 2023$159 M
Mar 2024$121 M
Jun 2024$125 M
Sep 2024$139 M
Dec 2024$171 M
Mar 2025$143 M
Jun 2025$121 M
Sep 2025$166 M
Dec 2025$145 M
Mar 2026$102 M
Jun 2026$170 M

Free cash

  • Free cash $320 M
Free cash
QuarterFree cash
Sep 2023$524 M
Dec 2023$326 M
Mar 2024−$256 M
Jun 2024$674 M
Sep 2024$671 M
Dec 2024$377 M
Mar 2025$36.8 M
Jun 2025$203 M
Sep 2025$675 M
Dec 2025$395 M
Mar 2026$219 M
Jun 2026$320 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is DaVita's P/E ratio, and how does it compare with its own history?

DaVita Inc.'s P/E is 14.2×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 14.2× against a usual —: with too little history to compare

  • P/E 15.8×
P/E 14.2× against a usual —: with too little history to compare
WeekP/E
1 Apr 202213.6×
14 Apr 202214.4×
29 Apr 202212.9×
13 May 202211.9×
27 May 202211.6×
10 Jun 202211.1×
24 Jun 20229.22×
8 Jul 202210.3×
22 Jul 202210.8×
5 Aug 202210.6×
19 Aug 202211.6×
2 Sep 202210.9×
16 Sep 202211.5×
30 Sep 202212.1×
14 Oct 202213.1×
28 Oct 202210.3×
11 Nov 202210.5×
25 Nov 202210.8×
9 Dec 202210.9×
23 Dec 202210.8×
6 Jan 202311.9×
20 Jan 202311.8×
3 Feb 202312.5×
17 Feb 202312.3×
3 Mar 202312.0×
17 Mar 202311.2×
31 Mar 202312.9×
14 Apr 202313.3×
28 Apr 202314.4×
12 May 202314.9×
26 May 202315.0×
9 Jun 202315.5×
23 Jun 202315.5×
7 Jul 202315.8×
21 Jul 202315.6×
4 Aug 202316.5×
18 Aug 202315.4×
1 Sep 202315.6×
15 Sep 202314.9×
29 Sep 202314.3×
13 Oct 202310.6×
27 Oct 202311.1×
10 Nov 202312.0×
24 Nov 202314.4×
8 Dec 202315.6×
22 Dec 202315.1×
5 Jan 202414.5×
19 Jan 202414.2×
2 Feb 202415.0×
16 Feb 202416.5×
1 Mar 202417.1×
15 Mar 202418.5×
28 Mar 202418.7×
12 Apr 202414.8×
26 Apr 202415.2×
10 May 202415.6×
24 May 202415.7×
7 Jun 202416.3×
21 Jun 202416.1×
5 Jul 202414.5×
19 Jul 202414.7×
2 Aug 202414.9×
16 Aug 202416.0×
30 Aug 202416.1×
13 Sep 202417.4×
27 Sep 202417.4×
11 Oct 202417.4×
25 Oct 202416.9×
8 Nov 202416.1×
22 Nov 202417.9×
6 Dec 202417.3×
20 Dec 202416.4×
3 Jan 202514.2×
17 Jan 202515.5×
31 Jan 202516.4×
14 Feb 202514.7×
28 Feb 202513.8×
14 Mar 202513.4×
28 Mar 202514.0×
11 Apr 202515.4×
25 Apr 202513.8×
9 May 202514.3×
23 May 202513.7×
6 Jun 202513.7×
20 Jun 202513.6×
3 Jul 202514.0×
18 Jul 202513.9×
1 Aug 202513.6×
15 Aug 202513.3×
29 Aug 202513.6×
12 Sep 202513.1×
26 Sep 202512.9×
10 Oct 202512.8×
24 Oct 202513.3×
7 Nov 202512.7×
21 Nov 202512.4×
5 Dec 202512.1×
19 Dec 202511.9×
2 Jan 202611.6×
16 Jan 202610.6×
30 Jan 202611.0×
13 Feb 202615.0×
27 Feb 202615.8×
13 Mar 202615.2×
27 Mar 202615.6×
10 Apr 202613.9×
24 Apr 202614.1×
8 May 202618.4×
22 May 202618.4×
5 Jun 202617.8×
18 Jun 202619.3×
2 Jul 202619.2×
17 Jul 202619.3×
31 Jul 202619.3×
14 Aug 202614.7×
28 Aug 202614.8×
11 Sep 202614.9×
25 Sep 202614.6×
9 Oct 202614.7×
23 Oct 202615.0×
4 Nov 202615.8×

Earnings per share, 12 months

  • Earnings per share, 12 months $12.22
Earnings per share, 12 months
WeekEarnings per share, 12 months
1 Apr 2022–
14 Apr 2022–
29 Apr 2022–
13 May 2022–
27 May 2022–
10 Jun 2022–
24 Jun 2022$8.40
8 Jul 2022$8.40
22 Jul 2022$8.40
5 Aug 2022$8.40
19 Aug 2022$8.40
2 Sep 2022$8.40
16 Sep 2022$8.40
30 Sep 2022$6.83
14 Oct 2022$6.83
28 Oct 2022$6.83
11 Nov 2022$6.83
25 Nov 2022$6.83
9 Dec 2022$6.83
23 Dec 2022$6.83
6 Jan 2023$6.83
20 Jan 2023$6.83
3 Feb 2023$6.83
17 Feb 2023$6.83
3 Mar 2023$6.83
17 Mar 2023$6.83
31 Mar 2023$6.29
14 Apr 2023$6.29
28 Apr 2023$6.29
12 May 2023$6.29
26 May 2023$6.29
9 Jun 2023$6.29
23 Jun 2023$6.59
7 Jul 2023$6.59
21 Jul 2023$6.59
4 Aug 2023$6.59
18 Aug 2023$6.59
1 Sep 2023$6.59
15 Sep 2023$6.59
29 Sep 2023$6.59
13 Oct 2023$6.59
27 Oct 2023$6.59
10 Nov 2023$6.59
24 Nov 2023$6.59
8 Dec 2023$6.59
22 Dec 2023$6.59
5 Jan 2024$6.91
19 Jan 2024$6.91
2 Feb 2024$6.91
16 Feb 2024$6.91
1 Mar 2024$6.91
15 Mar 2024$6.91
28 Mar 2024$7.40
12 Apr 2024$7.40
26 Apr 2024$7.40
10 May 2024$7.40
24 May 2024$7.40
7 Jun 2024$7.40
21 Jun 2024$8.80
5 Jul 2024$8.80
19 Jul 2024$8.80
2 Aug 2024$8.80
16 Aug 2024$8.80
30 Aug 2024$8.80
13 Sep 2024$8.80
27 Sep 2024$9.39
11 Oct 2024$9.39
25 Oct 2024$9.39
8 Nov 2024$9.39
22 Nov 2024$9.39
6 Dec 2024$9.39
20 Dec 2024$9.39
3 Jan 2025$9.27
17 Jan 2025$9.27
31 Jan 2025$9.27
14 Feb 2025$9.27
28 Feb 2025$9.27
14 Mar 2025$9.27
28 Mar 2025$10.74
11 Apr 2025$10.74
25 Apr 2025$10.74
9 May 2025$10.74
23 May 2025$10.74
6 Jun 2025$10.74
20 Jun 2025$10.74
3 Jul 2025$10.09
18 Jul 2025$10.09
1 Aug 2025$10.09
15 Aug 2025$10.09
29 Aug 2025$10.09
12 Sep 2025$10.09
26 Sep 2025$10.17
10 Oct 2025$10.17
24 Oct 2025$10.17
7 Nov 2025$10.17
21 Nov 2025$10.17
5 Dec 2025$10.17
19 Dec 2025$10.17
2 Jan 2026$9.71
16 Jan 2026$9.71
30 Jan 2026$9.71
13 Feb 2026$9.71
27 Feb 2026$9.71
13 Mar 2026$9.71
27 Mar 2026$9.91
10 Apr 2026$9.91
24 Apr 2026$9.91
8 May 2026$9.91
22 May 2026$9.91
5 Jun 2026$9.91
18 Jun 2026$9.91
2 Jul 2026$10.78
17 Jul 2026$10.78
31 Jul 2026$10.78
14 Aug 2026$10.78
28 Aug 2026$10.78
11 Sep 2026$10.78
25 Sep 2026$12.22
9 Oct 2026$12.22
23 Oct 2026$12.22
4 Nov 2026$12.22
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 4.6 years of history; short peaks above 19× are drawn at the top edge.

PEG 0.56 at the Jun 2026 quarter end: below 1.0, so the P/E is smaller than the earnings growth rate

  • PEG 0.56×
  • PEG = 1.0 1.00×
PEG 0.56 at the Jun 2026 quarter end: below 1.0, so the P/E is smaller than the earnings growth rate
QuarterPEGPEG = 1.0
Sep 20210.76×1.00×
Dec 20211.27×1.00×
Mar 20221.33×1.00×
Jun 20220.91×1.00×
Sep 20221.19×1.00×
Dec 20221.39×1.00×
Mar 20230.99×1.00×
Jun 20231.09×1.00×
Sep 20230.85×1.00×
Dec 20230.75×1.00×
Mar 20241.15×1.00×
Jun 20241.00×1.00×
Sep 20240.83×1.00×
Dec 20240.78×1.00×
Mar 20251.13×1.00×
Jun 20250.96×1.00×
Sep 20250.91×1.00×
Dec 20250.73×1.00×
Mar 20260.42×1.00×
Jun 20260.56×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 20 quarters.
14.2×P/E · too little history to compare
0.42PEG · today, as reported

Why the multiple is where it is: over the past year earnings per share moved −8.3% while the price moved +55.8%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 3 years the price moved +34.3% a year; about +20.9% a year came from earnings growth and about +13.4 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.

Is the DaVita business getting better or worse?

DaVita Inc.'s business is giving mixed signals. Growth has been steadily positive, but ROCE at 14.3% is below the 15% level needed to call it steady growth. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +6.5% in FY25, profit −13.8%

  • Revenue growth 6.5%
Growth year by year: revenue +6.5% in FY25, profit −13.8%
QuarterRevenue growth
FY21–
FY22−0.1%
FY234.6%
FY245.6%
FY256.5%

Profit growth, EPS growth

  • Profit growth −13.8%
  • EPS growth −8.3%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22−35.5%−34.3%
FY2322.4%26.8%
FY2430.7%44.6%
FY25−13.8%−8.3%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue stabilising, profit stabilising

  • Revenue 6.4%
Three growth lines over twelve quarters: revenue stabilising, profit stabilising
QuarterRevenue
Sep 20232.7%
Dec 20234.3%
Mar 20246.7%
Jun 20246.6%
Sep 20246.1%
Dec 20245.6%
Mar 20255.1%
Jun 20255.1%
Sep 20255.1%
Dec 20256.5%
Mar 20266.7%
Jun 20266.4%

Profit, EPS

  • Profit 3.2%
  • EPS 20.2%
Profit, EPS
QuarterProfitEPS
Sep 2023−15.9%−14.3%
Dec 20235.8%8.3%
Mar 202432.3%39.9%
Jun 202432.2%42.5%
Sep 202427%34.1%
Dec 202430.7%45.2%
Mar 20257.8%14.7%
Jun 20250.6%8.3%
Sep 2025−3.1%4.8%
Dec 2025−13.8%−7.7%
Mar 2026−4.7%6.8%
Jun 20263.2%20.2%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 14.3%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 202310.2%
Dec 202310.5%
Mar 202411.3%
Jun 202412.2%
Sep 202412.4%
Dec 202413.7%
Mar 202513.4%
Jun 202513.8%
Sep 202513.4%
Dec 202514.1%
Mar 202614.3%
Jun 202614.3%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +6.4%, range +2.7% to +6.7%
FlatProfit growth · latest +3.2%, range −15.9% to +32.3%
RisingEPS growth · latest +20.2%, range −14.3% to +45.2%
Stuck lowROCE · latest 14.3%, range 10.2% to 14.3%

Why it matters: when the lines disagree, each line above matters more than any single label.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+6.5%+5.5%——
Profit−13.8%+11.3%——
EPS−8.3%+18.9%——
Stock price+55.8%+34.3%+12.0%+12.6%
+5.2%Revenue growth (Jun 2026) · latest quarter against a year ago
+24.7%Profit growth (Jun 2026) · latest quarter against a year ago
4.1%Revenue, 4 years · yearly growth over the long run

How much does DaVita earn on its capital?

DaVita Inc. earned a ROE of 93% in FY25. That is up from a low of 35% in FY23. Its return on capital used (ROIC) is 6.3 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 7.9% net margin and 0.78× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 7.9% net margin × 0.78× asset turnover × 15.09× leverage (assets divided by equity) ≈ 93.0% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 12.2% − 5.9% = +6.3 percentage points. The 5.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value.

FY25: ROE 93%, the climb back from FY23's 35%

  • ROE 93.1%
  • ROIC (annual) 12%
  • Cost of capital 5.9%
FY25: ROE 93%, the climb back from FY23's 35%
QuarterROEROIC (annual)Cost of capital
FY2151.1%10.2%5.9%
FY2235.1%7.6%5.9%
FY2334.9%9.6%5.9%
FY2459.8%11.9%5.9%
FY2593.1%12%5.9%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 5.9% cost of capital used on this page.

Jun 2026: ROIC 11.9% (last 12 months) against a 5.9% cost of capital

  • ROIC (12 months) 11.9%
  • ROE (12 months) 99.7%
  • Cost of capital 5.9%
Jun 2026: ROIC 11.9% (last 12 months) against a 5.9% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 20238.4%39%5.9%
Dec 20238.8%45.4%5.9%
Mar 20249%33.1%5.9%
Jun 20249.8%45.5%5.9%
Sep 202410.3%47.4%5.9%
Dec 202410.5%50.9%5.9%
Mar 202511.6%64.8%5.9%
Jun 202511.6%49.5%5.9%
Sep 202511.6%68.5%5.9%
Dec 202511.4%66.4%5.9%
Mar 202611.7%98%5.9%
Jun 202611.9%99.7%5.9%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does DaVita have too much debt?

DaVita Inc. has total debt of $13.4 B against shareholder equity of $1.1 B as of Jun 2026, so its debt is 12.42× its equity. Year by year, that ratio went from 5.05 in FY21 to 11.11 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $12.9 B, 11.11× equity

  • Total debt $12.9 B
FY25: debt $12.9 B, 11.11× equity
QuarterTotal debt
FY21$12.0 B
FY22$11.8 B
FY23$11.1 B
FY24$12.1 B
FY25$12.9 B

Debt-to-equity

  • Debt-to-equity 11.1×
Debt-to-equity
QuarterDebt-to-equity
FY215.05×
FY225.31×
FY234.05×
FY245.77×
FY2511.1×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $13.4 B, debt-to-equity 12.42

  • Total debt (quarterly) $13.4 B
Jun 2026: debt $13.4 B, debt-to-equity 12.42
QuarterTotal debt (quarterly)
Sep 2023$11.1 B
Dec 2023$11.1 B
Mar 2024$11.8 B
Jun 2024$11.7 B
Sep 2024$12.2 B
Dec 2024$12.1 B
Mar 2025$12.3 B
Jun 2025$12.8 B
Sep 2025$12.8 B
Dec 2025$12.9 B
Mar 2026$13.2 B
Jun 2026$13.4 B

Debt-to-equity

  • Debt-to-equity 12.4×
Debt-to-equity
QuarterDebt-to-equity
Sep 20233.94×
Dec 20234.05×
Mar 20244.49×
Jun 20244.82×
Sep 20245.50×
Dec 20245.77×
Mar 20257.42×
Jun 20258.25×
Sep 20259.53×
Dec 202511.1×
Mar 202612.6×
Jun 202612.4×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the DaVita shareholding pattern?

14.7% of DaVita Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 7.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

14.7%Short interest · of the tradable float
7.5Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is DaVita from balance-sheet trouble?

For DaVita Inc., the Z-score is 1.68. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 1.68 is inside the danger zone, so the balance sheet is a real risk.

How does DaVita rank in its industry?

47.9 out of 100, rank 20 of 30 in Medical Care Facilities, with 81% of the evidence available.

DaVita Inc. scores 47.9 out of 100 against the 30 companies it is compared with in Medical Care Facilities, ranking 20. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 14.4 + 15.8 + 11.6 + 6.1 = 47.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is DaVita compared with?

DaVita ranks 20 of 30 Medical Care Facilities companies on the 4-Factor Sector Score, with 47.9 out of 100.

  1. 1Concentra Group Holdings Parent, Inc.CON · leader · Most evidence points up · 81% evidence71.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.0/35 · Revenue 14% · Profit 32.6% · Operating margin change 2.3 points · 83% evidenceCapital efficiency 16.6/25 · ROCE 14.5% · Operating margin 19.3% · 76% evidenceValuation 12.8/20 · P/E 19.5× · PEG 0.65 · 65% evidenceRelative strength 18.5/20 · Lead over its industry 20.3% · Lead over S&P 500 51% · 1 year 125.2% · 100% evidence · 12 of 12 weeks aheadExact sum: 24 + 16.6 + 12.8 + 18.5 = 71.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Nutex Health Inc.NUTX · leader · Most evidence points up · 64% evidence66.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.5/35 · Revenue 6.8% · Profit 100% · Operating margin change 44 points · 62% evidenceCapital efficiency 18.7/25 · ROCE 56.8% · Operating margin 57.8% · 76% evidenceValuation 10.8/20 · P/E 6.5× · PEG — · 15% evidenceRelative strength 14.6/20 · Lead over its industry 1% · Lead over S&P 500 28% · 1 year 79% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.5 + 18.7 + 10.8 + 14.6 = 66.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Tenet Healthcare CorporationTHC · leader · Most evidence points up · 81% evidence65.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.8/35 · Revenue 5.4% · Profit 32.4% · Operating margin change 2.1 points · 83% evidenceCapital efficiency 17.1/25 · ROCE 15% · Operating margin 18.2% · 76% evidenceValuation 15.2/20 · P/E 7.2× · PEG 0.35 · 65% evidenceRelative strength 12.6/20 · Lead over its industry -1.3% · Lead over S&P 500 25.8% · 1 year 42.4% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.8 + 17.1 + 15.2 + 12.6 = 65.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4AMN Healthcare Services, Inc.AMN · breaking out · Evidence leans up · 64% evidence64.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.4/35 · Revenue 23.9% · Profit — · Operating margin change 3.4 points · 62% evidenceCapital efficiency 9.1/25 · ROCE 10.1% · Operating margin 4% · 76% evidenceValuation 10.3/20 · P/E 12× · PEG — · 15% evidenceRelative strength 19.3/20 · Lead over its industry 36.3% · Lead over S&P 500 69.4% · 1 year 167.2% · 100% evidence · 9 of 12 weeks aheadExact sum: 25.4 + 9.1 + 10.3 + 19.3 = 64.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5Pediatrix Medical Group, Inc.MD · turning · Evidence leans up · 81% evidence61.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.1/35 · Revenue 0.6% · Profit 61.5% · Operating margin change -0.2 points · 83% evidenceCapital efficiency 14.6/25 · ROCE 14.8% · Operating margin 13.4% · 76% evidenceValuation 12.8/20 · P/E 11.6× · PEG 0.8 · 65% evidenceRelative strength 15.4/20 · Lead over its industry 1.6% · Lead over S&P 500 29.5% · 1 year 49.6% · 100% evidence · 8 of 12 weeks aheadExact sum: 19.1 + 14.6 + 12.8 + 15.4 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Healthcare Services Group, Inc.HCSG · turning · Evidence leans up · 85% evidence60.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.4/35 · Revenue 4% · Profit 100% · Operating margin change -3.2 points · 95% evidenceCapital efficiency 14.6/25 · ROCE 17.7% · Operating margin 6.7% · 76% evidenceValuation 14.3/20 · P/E 13.4× · PEG 0.43 · 65% evidenceRelative strength 11.0/20 · Lead over its industry -7.3% · Lead over S&P 500 18.3% · 1 year 53.8% · 100% evidence · 4 of 12 weeks aheadExact sum: 20.4 + 14.6 + 14.3 + 11 = 60.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Aveanna Healthcare Holdings Inc.AVAH · leader · Too little evidence to rank firmly · 58% evidence60.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 15.4/35 · Revenue — · Profit — · Operating margin change 1.6 points · 45% evidenceCapital efficiency 15.4/25 · ROCE 17.7% · Operating margin 12.6% · 76% evidenceValuation 10.6/20 · P/E 7.2× · PEG — · 15% evidenceRelative strength 18.6/20 · Lead over its industry 14.8% · Lead over S&P 500 45.2% · 1 year 62.6% · 100% evidence · 12 of 12 weeks aheadExact sum: 15.4 + 15.4 + 10.6 + 18.6 = 60 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  8. 8Encompass Health CorporationEHC · leader · Evidence leans up · 81% evidence59.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.5/35 · Revenue 9.5% · Profit 20.2% · Operating margin change 0.3 points · 83% evidenceCapital efficiency 18.1/25 · ROCE 17% · Operating margin 18.1% · 76% evidenceValuation 12.2/20 · P/E 16.2× · PEG 0.8 · 65% evidenceRelative strength 11.6/20 · Lead over its industry -6.7% · Lead over S&P 500 19.5% · 1 year 22.3% · 100% evidence · 12 of 12 weeks aheadExact sum: 17.5 + 18.1 + 12.2 + 11.6 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9HCA Healthcare, Inc.HCA · breaking out · Evidence leans up · 81% evidence58.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 15.4/35 · Revenue 7.3% · Profit 14.6% · Operating margin change -0.7 points · 83% evidenceCapital efficiency 19.9/25 · ROCE 26.3% · Operating margin 15.2% · 76% evidenceValuation 14.2/20 · P/E 12.6× · PEG 0.49 · 65% evidenceRelative strength 8.8/20 · Lead over its industry -18.7% · Lead over S&P 500 5.4% · 1 year 7.2% · 100% evidence · 10 of 12 weeks aheadExact sum: 15.4 + 19.9 + 14.2 + 8.8 = 58.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far.
  10. 10Universal Health Services, Inc.UHS · breaking out · Evidence leans up · 81% evidence57.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.8/35 · Revenue 10% · Profit 21% · Operating margin change -0.6 points · 83% evidenceCapital efficiency 16.4/25 · ROCE 16.3% · Operating margin 11.1% · 76% evidenceValuation 15.9/20 · P/E 5.9× · PEG 0.2 · 65% evidenceRelative strength 6.6/20 · Lead over its industry -24.5% · Lead over S&P 500 -1.6% · 1 year -14.3% · 100% evidence · 11 of 12 weeks aheadExact sum: 18.8 + 16.4 + 15.9 + 6.6 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11LifeStance Health Group, Inc.LFST · turning · Evidence leans up · 64% evidence56.1out of 100GrowthCapitalValuationRelative
  12. 12Addus HomeCare CorporationADUS · turning · Evidence leans up · 81% evidence55.6out of 100GrowthCapitalValuationRelative
  13. 13PACS Group, Inc.PACS · turning · Evidence leans up · 71% evidence53.5out of 100GrowthCapitalValuationRelative
  14. 14National HealthCare CorporationNHC · quiet · Evidence leans up · 81% evidence53.1out of 100GrowthCapitalValuationRelative
  15. 15Fresenius Medical Care AGFMS · basing · Evidence leans up · 81% evidence50.7out of 100GrowthCapitalValuationRelative
  16. 16Guardian Pharmacy Services, Inc.GRDN · quiet · Evidence leans down · 64% evidence49.3out of 100GrowthCapitalValuationRelative
  17. 17Chemed CorporationCHE · turning · Evidence leans down · 81% evidence48.5out of 100GrowthCapitalValuationRelative
  18. 18Astrana Health, Inc.ASTH · turning · Evidence leans down · 81% evidence48.1out of 100GrowthCapitalValuationRelative
  19. 19Surgery Partners, Inc.SGRY · turning · Evidence leans down · 64% evidence48.1out of 100GrowthCapitalValuationRelative
  20. 20DaVita Inc. this pageDVA · turning · Evidence leans down · 81% evidence47.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 14.4/35 · Revenue 6.4% · Profit 3.2% · Operating margin change 0.4 points · 83% evidenceCapital efficiency 15.8/25 · ROCE 14.2% · Operating margin 16.1% · 76% evidenceValuation 11.6/20 · P/E 16.9× · PEG 0.84 · 65% evidenceRelative strength 6.1/20 · Lead over its industry -13.6% · Lead over S&P 500 9.1% · 1 year 55.8% · 100% evidence · 1 of 12 weeks aheadExact sum: 14.4 + 15.8 + 11.6 + 6.1 = 47.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  21. 21The Pennant Group, Inc.PNTG · turning · Evidence leans down · 81% evidence44.1out of 100GrowthCapitalValuationRelative
  22. 22The Ensign Group, Inc.ENSG · turning · Evidence leans down · 81% evidence41.8out of 100GrowthCapitalValuationRelative
  23. 23agilon health, inc.AGL · turning · Evidence leans down · 64% evidence41.3out of 100GrowthCapitalValuationRelative
  24. 24InnovAge Holding Corp.INNV · quiet · Evidence leans down · 64% evidence39.9out of 100GrowthCapitalValuationRelative
  25. 25Acadia Healthcare Company, Inc.ACHC · turning · Evidence leans down · 71% evidence39.4out of 100GrowthCapitalValuationRelative
  26. 26Option Care Health, Inc.OPCH · breaking out · Evidence leans down · 81% evidence39.3out of 100GrowthCapitalValuationRelative
  27. 27Ardent Health, Inc.ARDT · breaking out · Evidence leans down · 71% evidence37.8out of 100GrowthCapitalValuationRelative
  28. 28Sonida Senior Living, Inc.SNDA · quiet · Evidence leans down · 64% evidence36.8out of 100GrowthCapitalValuationRelative
  29. 29Brookdale Senior Living Inc.BKD · quiet · Most evidence points down · 64% evidence32.9out of 100GrowthCapitalValuationRelative
  30. 30Select Medical Holdings CorporationSEM · Too little evidence to rank firmly · 36% evidence50.6out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Care Facilities, all 30 compared on one page.

Which companies are close to DaVita in size?

DaVita is the 5th largest of 38 Medical Care Facilities companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Tenet Healthcare Corporation, Encompass Health Corporation and Fresenius Medical Care AG. Just below it: Universal Health Services, Inc., The Ensign Group, Inc. and PACS Group, Inc.

Medical Care Facilities companies close in size

  1. Tenet Healthcare Corporation $23.3 billion
  2. Encompass Health Corporation $13.8 billion
  3. Fresenius Medical Care AG $12.7 billion
  4. DaVita Inc. $12.1 billion
  5. Universal Health Services, Inc. $11.6 billion
  6. The Ensign Group, Inc. $10.9 billion
  7. PACS Group, Inc. $8 billion

All 38 Medical Care Facilities companies, largest first

Companies close in size in other industries

  1. Rentokil Initial plc $12.2 billion · Specialty Business Services
  2. SiTime Corporation $12.1 billion · Semiconductors
  3. DaVita Inc. $12.1 billion
  4. Dr. Reddy's Laboratories Limited $12.1 billion · Drug Manufacturers - Specialty & Generic
  5. FactSet Research Systems Inc. $12.1 billion · Financial Data & Stock Exchanges

What else do people ask about DaVita?

What were DaVita's latest quarterly results?

DaVita Inc. reported revenue of $3.6 B and net profit of $343 M for the Jun 2026 quarter. Revenue rose 5.2% and profit rose 24.7% compared with a year earlier. Earnings per share were $4.02.

The operating margin was 16.1%, 0.4 percentage points higher than a year earlier (as of 4 November 2026).

What is DaVita's market cap?

DaVita Inc.'s market capitalisation is $12.1 B at a stock price of $192.66. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is DaVita performing?

DaVita Inc.'s share price has been rising for 21 weeks. In its latest quarter, revenue rose 5.2% and profit rose 24.7% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 4 November 2026).

Will DaVita's stock price go up?

This page does not forecast DaVita Inc.'s stock price. What it shows instead: the stock price is $192.66, and it has been rising for 21 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Does DaVita have too much debt?

Yes, DaVita Inc. has a lot of debt: its debt is 11.90× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 4 November 2026).

Where is DaVita in its business cycle?

DaVita Inc.'s FY25 operating margin was 14.9%, against a 5-year range of 11.3% to 15.3%: the middle of its own range, neither a peak nor a low. The latest quarter was 16.1%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the DaVita story?

The main question: the share price moved +55.8% in a year while yearly earnings per share moved −8.3%. The difference came from the market paying a higher multiple.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is DaVita a stock worth studying right now?

What the numbers show: DaVita Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.